Form 6-K Satellos Bioscience Inc. For: Mar 27
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2026
Commission File Number: 001-43107
SATELLOS BIOSCIENCE INC.
(Translation of registrant's name into English)
Royal Bank Plaza, South Tower, 200 Bay Street, Suite 2800
Toronto, Ontario, ON M5J 2J3
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ ] Form 40-F [ X ]
DOCUMENTS INCLUDED AS PART OF THIS FORM 6-K
| Exhibit | Description | |
| 99.1 | Satellos Reports 2025 Financial Results and Highlights Recent Company Progress |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| SATELLOS BIOSCIENCE INC. | ||
| (Registrant) | ||
| Date: March 27, 2026 | /s/ Elizabeth Williams, CPA, CA | |
| Elizabeth Williams, CPA, CA | ||
| Chief Financial Officer | ||
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Satellos drug candidate SAT-3247 receives WHO nonproprietary name
- Crypto Bull Run Signs Are Stacking Fast and Pepeto Is the One Presale That Could Turn $500 Into Real Money
- Invidia Funded prepares its launch: the funded division of InvidiaTrade arrives with the most competitive conditions in the market
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
